These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 28977631)
1. Producing irreversible topoisomerase II-mediated DNA breaks by site-specific Pt(II)-methionine coordination chemistry. Wang YR; Chen SF; Wu CC; Liao YW; Lin TS; Liu KT; Chen YS; Li TK; Chien TC; Chan NL Nucleic Acids Res; 2017 Oct; 45(18):10861-10871. PubMed ID: 28977631 [TBL] [Abstract][Full Text] [Related]
2. Increasing the distance between two monomers of topoisomerase IIβ under the action of antitumor agent 4β-sulfur-(benzimidazole) 4'-demethylepipodophyllotoxin. Sun LY; Zhu LW; Tang YJ Sci Rep; 2018 Oct; 8(1):14949. PubMed ID: 30297860 [TBL] [Abstract][Full Text] [Related]
3. On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs. Wu CC; Li YC; Wang YR; Li TK; Chan NL Nucleic Acids Res; 2013 Dec; 41(22):10630-40. PubMed ID: 24038465 [TBL] [Abstract][Full Text] [Related]
4. Anthracenedione-methionine conjugates are novel topoisomerase II-targeting anticancer agents with favorable drug resistance profiles. Lee CH; Hsieh MY; Hsin LW; Chen HC; Lo SC; Fan JR; Chen WR; Chen HW; Chan NL; Li TK Biochem Pharmacol; 2012 May; 83(9):1208-16. PubMed ID: 22306066 [TBL] [Abstract][Full Text] [Related]
5. Interactions between the etoposide derivative F14512 and human type II topoisomerases: implications for the C4 spermine moiety in promoting enzyme-mediated DNA cleavage. Gentry AC; Pitts SL; Jablonsky MJ; Bailly C; Graves DE; Osheroff N Biochemistry; 2011 Apr; 50(15):3240-9. PubMed ID: 21413765 [TBL] [Abstract][Full Text] [Related]
6. Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide. Wu CC; Li TK; Farh L; Lin LY; Lin TS; Yu YJ; Yen TJ; Chiang CW; Chan NL Science; 2011 Jul; 333(6041):459-62. PubMed ID: 21778401 [TBL] [Abstract][Full Text] [Related]
7. Structure-based design, synthesis and biological testing of etoposide analog epipodophyllotoxin-N-mustard hybrid compounds designed to covalently bind to topoisomerase II and DNA. Yadav AA; Wu X; Patel D; Yalowich JC; Hasinoff BB Bioorg Med Chem; 2014 Nov; 22(21):5935-49. PubMed ID: 25282653 [TBL] [Abstract][Full Text] [Related]
8. Topoisomerase II-Induced Chromosome Breakage and Translocation Is Determined by Chromosome Architecture and Transcriptional Activity. Canela A; Maman Y; Huang SN; Wutz G; Tang W; Zagnoli-Vieira G; Callen E; Wong N; Day A; Peters JM; Caldecott KW; Pommier Y; Nussenzweig A Mol Cell; 2019 Jul; 75(2):252-266.e8. PubMed ID: 31202577 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of etoposide and podophyllotoxin analogs against topoisomerase IIα and HCT-116 cells. Murphy MB; Kumar P; Bradley AM; Barton CE; Deweese JE; Mercer SL Bioorg Med Chem; 2020 Nov; 28(22):115773. PubMed ID: 33035756 [TBL] [Abstract][Full Text] [Related]
10. NK314, a topoisomerase II inhibitor that specifically targets the alpha isoform. Toyoda E; Kagaya S; Cowell IG; Kurosawa A; Kamoshita K; Nishikawa K; Iiizumi S; Koyama H; Austin CA; Adachi N J Biol Chem; 2008 Aug; 283(35):23711-20. PubMed ID: 18596031 [TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity and cell death mechanisms induced by the polyamine-vectorized anti-cancer drug F14512 targeting topoisomerase II. Brel V; Annereau JP; Vispé S; Kruczynski A; Bailly C; Guilbaud N Biochem Pharmacol; 2011 Dec; 82(12):1843-52. PubMed ID: 21924246 [TBL] [Abstract][Full Text] [Related]
12. Replication-dependent and transcription-dependent mechanisms of DNA double-strand break induction by the topoisomerase 2-targeting drug etoposide. Tammaro M; Barr P; Ricci B; Yan H PLoS One; 2013; 8(11):e79202. PubMed ID: 24244448 [TBL] [Abstract][Full Text] [Related]
13. Substituents on etoposide that interact with human topoisomerase IIalpha in the binary enzyme-drug complex: contributions to etoposide binding and activity. Bender RP; Jablonksy MJ; Shadid M; Romaine I; Dunlap N; Anklin C; Graves DE; Osheroff N Biochemistry; 2008 Apr; 47(15):4501-9. PubMed ID: 18355043 [TBL] [Abstract][Full Text] [Related]
14. FEN1 participates in repair of the 5'-phosphotyrosyl terminus of DNA single-strand breaks. Kametani Y; Takahata C; Narita T; Tanaka K; Iwai S; Kuraoka I Carcinogenesis; 2016 Jan; 37(1):56-62. PubMed ID: 26581212 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and Biological Evaluation of Pyrazolo[3,4-b]pyridin-4-ones as a New Class of Topoisomerase II Inhibitors. Tabrizi MA; Baraldi PG; Baraldi S; Prencipe F; Preti D; Saponaro G; Romagnoli R; Gessi S; Merighi S; Stefanelli A; Fazzi D; Borea PA; Maia RC; Romeiro NC; Fraga CA; Barreiro EJ Med Chem; 2015; 11(4):342-53. PubMed ID: 25494808 [TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of the novel DNA topoisomerase II inhibitors: esterification and amination substituted 4'-demethylepipodophyllotoxin derivates exhibiting anti-tumor activity by activating ATM/ATR signaling pathways. Xiao L; Zhao W; Li HM; Wan DJ; Li DS; Chen T; Tang YJ Eur J Med Chem; 2014 Jun; 80():267-77. PubMed ID: 24793877 [TBL] [Abstract][Full Text] [Related]
17. QS-ZYX-1-61 induces apoptosis through topoisomerase II in human non-small-cell lung cancer A549 cells. Chen MC; Pan SL; Shi Q; Xiao Z; Lee KH; Li TK; Teng CM Cancer Sci; 2012 Jan; 103(1):80-7. PubMed ID: 21920000 [TBL] [Abstract][Full Text] [Related]
18. NPRL-Z-1, as a new topoisomerase II poison, induces cell apoptosis and ROS generation in human renal carcinoma cells. Wu SY; Pan SL; Xiao ZY; Hsu JL; Chen MC; Lee KH; Teng CM PLoS One; 2014; 9(11):e112220. PubMed ID: 25372714 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of podophyllotoxin linked β-carboline congeners as potential anticancer agents and DNA topoisomerase II inhibitors. Sathish M; Kavitha B; Nayak VL; Tangella Y; Ajitha A; Nekkanti S; Alarifi A; Shankaraiah N; Nagesh N; Kamal A Eur J Med Chem; 2018 Jan; 144():557-571. PubMed ID: 29289881 [TBL] [Abstract][Full Text] [Related]
20. Polyamine-containing etoposide derivatives as poisons of human type II topoisomerases: Differential effects on topoisomerase IIα and IIβ. Oviatt AA; Kuriappan JA; Minniti E; Vann KR; Onuorah P; Minarini A; De Vivo M; Osheroff N Bioorg Med Chem Lett; 2018 Sep; 28(17):2961-2968. PubMed ID: 30006062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]